This site is intended for healthcare professionals only
LoginRegister

Diabetes and Endocrinology Dialogues

5mg Dapagliflozin every day attenuates CV events among diabetes patients with chronic HF

5mg Dapagliflozin every day attenuates CV events among diabetes patients with chronic HF

The DAPPER study was conducted with the National Cardiovascular Center as the principal investigator, with 294 patients participating from 18...
View All

Latest News and Guidelines

Empagliflozin may not exhibit clinical or mortality benefit in COVID-19 patients

Empagliflozin may not exhibit clinical or mortality benefit in COVID-19 patients

Supplement lowers risk of higher glucose caused by thiazides

Supplement lowers risk of higher glucose caused by thiazides

Green coffee may help improve lipid profile and inflammation in diabetes patients: Study

Green coffee may help improve lipid profile and inflammation in diabetes patients: Study

RPG Dietary fibre may help enhance satiety and reduce postprandial glucose

RPG Dietary fibre may help enhance satiety and reduce postprandial glucose

Newly found metabolic biomarker of Avacado may lower fasting glucose, insulin and incidence of T2D

Newly found metabolic biomarker of Avacado may lower fasting glucose, insulin and incidence of T2D

First Indian Evidence: Triple FDC (DAPA, SITA, MET ER) Yields Better HbA1c Reduction in T2DM Patients Uncontrolled on Existing Therapy

First Indian Evidence: Triple FDC (DAPA, SITA, MET ER) Yields Better HbA1c Reduction in T2DM...

View All
X